Compounds > n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine
Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and monorden

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with monorden in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Studies
(monorden)		Trials
(monorden)		Recent Studies (post-2010) (monorden)
79116341099

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)monorden (IC50)
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1Homo sapiens (human)400
Chain A [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3Homo sapiens (human)400
ATP-dependent molecular chaperone HSP82Saccharomyces cerevisiae S288C0.1193
Heat shock protein HSP 90-alphaHomo sapiens (human)0.2092
Heat shock protein HSP 90-betaHomo sapiens (human)0.1148
ATP-dependent molecular chaperone HSC82Saccharomyces cerevisiae S288C0.2
Carbonyl reductase [NADPH] 1Homo sapiens (human)3.27
Prostaglandin G/H synthase 2Homo sapiens (human)0.027
Proto-oncogene tyrosine-protein kinase Src Rattus norvegicus (Norway rat)0.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and monorden

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012